Phenylamino isonicotinamide compounds
    8.
    发明授权
    Phenylamino isonicotinamide compounds 有权
    苯氨基异烟酰胺化合物

    公开(公告)号:US08404725B2

    公开(公告)日:2013-03-26

    申请号:US13057052

    申请日:2009-07-27

    IPC分类号: A61K31/455 C07D213/46

    摘要: The invention provides novel substituted phenylamino isonicotinamide compounds (I), pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein X, R1, R2, R3, R4, R5 and R6 are as defined in the specification. Said compounds are MEK inhibitors useful in the treatment of hyperproliferative diseases related to the hyperactivity of MEK, such as restenosis, as well as diseases modulated by the MEK cascade, such as cancer and inflammation. Also disclosed is the use of such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and pharmaceutical compositions containing such compounds.

    摘要翻译: 本发明提供新的取代的苯基氨基异烟酰胺化合物(I),其药学上可接受的盐,溶剂合物或前药,其中X,R 1,R 2,R 3,R 4,R 5和R 6如说明书中所定义。 所述化合物是可用于治疗与MEK的多动症相关的过度增生性疾病的MEK抑制剂,例如再狭窄,以及由MEK级联调节的疾病,例如癌症和炎症。 还公开了这样的化合物在哺乳动物,特别是人类中过度增殖性疾病的治疗和含有这些化合物的药物组合物中的应用。